Back to search

Article

The splicing factor SRSF6 regulates AR activity and represents a potential therapeutic target in prostate cancer

2023-05-08

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold> Prostate cancer (PCa) is the fifth leading cause of cancer-related death worldwide. Finding novel therapeutic strategies to tackle PCa, especially its most advanced phenotype, named castration-resistant PCa (CRPC), is urgently needed. In this sense, although the dysregulation of the splicing process has emerged as a distinctive feature of advanced PCa, the potent...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e3b7d1da-f2ab-5e68-814e-e1662821d4ad
DOI
10.21203/rs.3.rs-2885147/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The splicing factor SRSF6 regulates AR activity and represents a potential therapeutic target in prostate cancerDOI 10.21203/rs.3.rs-2885147/v1
Select a neighboring publication to make it the new centre.